SUBJECTS : Therapeutics | Pharmacology | Antibodie
Antibody Therapeutics: 2022, vol: 5, issue: 4
- 1)- Xiaochen Lyu, Qichao Zhao, Julia Hui, Tiffany Wang, Mengyi Lin, Keying Wang, Jialing Zhang, Jiaqian Shentu, Paul A Dalby, Hongyu Zhang, Bo Liu. The global landscape of approved antibody therapies. Antibody therapeutics. 2022, 5 (4): 233-257
Cited : 17Read More - 2)- Ruth Bone, Brian J Fennell, Amy Tam, Richard Sheldon, Karl Nocka, Sreeja Varghese, Chew Shun Chang, Heike C Hawerkamp, Aoife Yeow, Sean P Saunders, Emily Hams, Patrick T Walsh, Orla Cunningham, Padraic G Fallon. Discovery and multi-parametric optimization of a high-affinity antibody against interleukin-25 with neutralizing activity in a mouse model of skin inflammation. Antibody therapeutics. 2022, 5 (4): 258-267Cited : 2Read More
- 3)- Ehsan Espah Borujeni, Weixin Jin, Chun Shao, Naresh Chennamsetty, Xuankuo Xu, Sanchayita Ghose. Role of harvest depth filtration in controlling product-related impurities for a bispecific antibody. Antibody therapeutics. 2022, 5 (4): 268-279Cited : 0Read More
- 4)- Yong Zhu, Shawn Shouye Wang, Zhaohui Sunny Zhou, Mitchell Ho. The emergence of AntibodyPlus: the future trend of antibody-based therapeutics. Antibody therapeutics. 2022, 5 (4): 280-287Cited : 2Read More
- 5)- Han Kee Ong, Ngan T B Nguyen, Jiawu Bi, Yuansheng Yang. Vector design for enhancing expression level and assembly of knob-into-hole based FabscFv-Fc bispecific antibodies in CHO cells. Antibody therapeutics. 2022, 5 (4): 288-300Cited : 2Read More
- 6)- Barbara Frigerio, Matilde Montermini, Canevari Silvana, Mariangela Figini. Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa. Antibody therapeutics. 2022, 5 (4): 301-310Cited : 1Read More
- 7)- Peng Zhao, Ningyan Zhang, Zhiqiang An. Engineering antibody and protein therapeutics to cross the blood-brain barrier. Antibody therapeutics. 2022, 5 (4): 311-331Cited : 4Read More
